Repeat CAPA investigations are arguably one of the largest areas of concern for Life Science organizations today. Despite many firms taking the recommended corrective action, repeat investigations throughout the industry have accounted for as many as up to 30% of all open investigations- or 1 in every 3.

What percentage of your quality system investigations are repeats?

Vote at http://www.surveymonkey.com/s/89X2LM3

Tags: corrective action, investigations, medical devices, pharmaceuticals, preventive action, quality systems

This entry was posted on Monday, June 7th, 2010 at 11:37 am and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.